Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1466]

FDA approves the use of dabrafenib for treatment of metastatic melanoma

FDA approves the use of dabrafenib for treatment of metastatic melanoma

FDA approves use of trametinib for treatment of unresectable or metastatic melanoma

FDA approves use of trametinib for treatment of unresectable or metastatic melanoma

Promising strategies to reduce use of indoor tanning devices and prevent skin cancer

Promising strategies to reduce use of indoor tanning devices and prevent skin cancer

Latin America risks being “overwhelmed” by burgeoning cancer epidemic

Latin America risks being “overwhelmed” by burgeoning cancer epidemic

AACR 2013: Study indicates novel inhibitor to overcome drug resistance induced by RAF, MEK inhibitors

AACR 2013: Study indicates novel inhibitor to overcome drug resistance induced by RAF, MEK inhibitors

AACR 2013: Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma

AACR 2013: Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma

Functional characteristics of antitumour T cells change with increasing time after therapeutic transfer

Functional characteristics of antitumour T cells change with increasing time after therapeutic transfer

Medical Education Workshop on Molecular Targeted Therapy of Cancer

Medical Education Workshop on Molecular Targeted Therapy of Cancer

BRAF inhibitor treatment causes melanoma cells to shift how they produce energy

BRAF inhibitor treatment causes melanoma cells to shift how they produce energy

Aspirin may lower melanoma risk

Aspirin may lower melanoma risk

More from ecancer